Diagnostic Histopathology
Volume 15, Issue 10 , Pages 459-469 , October 2009

Pathology of B3 lesions of the breast

References 

  1. NHS Cancer Screening Programmes . Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for Non-operative Diagnostic Procedures and Reporting in breast cancer screening. Sheffield: NHSBSP; 2001;
  2. Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In:  Tavassoli FA,  Devilee P editor. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003;p. 63–73
  3. Ghofrani M, Tapia B, Tavassoli FA. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch. 2006;449:609–616
  4. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953–958
  5. Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?. Cancer Epidemiol Biomarkers Prev. 2004;13:1569–1573
  6. Erbas B, Provenzano E, Armes J, Gertig G. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97:135–144
  7. Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer. 2008;98:137–142
  8. Roses RE, Paulson EC, Sharma A, et al. HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:OF1–OF4
  9. Tamimi RM, Baer HJ, Marotti J, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008;10:R67
  10. Tavassoli FA. Ductal intraepithelial neoplasia. In: Pathology of the breast. 2nd edn. Stamford, Connecticut: Appleton and Lange; 1999;p. 205–325
  11. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical hyperplasia. Hum Pathol. 1992;23:1095–1097
  12. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer. 1994;73:118–124
  13. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–237
  14. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–151
  15. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053–1055
  16. Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103:2481–2484
  17. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology. 1995;194:379–381
  18. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol. 1995;164:1111–1113
  19. Lee AHS, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology. 2003;42:331–336
  20. El-Sayed ME, Rakha EA, Reed J, Lee AHS, Evans AJ, Ellis IO. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology. 2008;53:650–657
  21. Dillon MF, McDermott EW, Hill AD, O'Doherty A, O'Higgins N, Quinn CM. Predictive value of breast lesions of “uncertain malignant potential” and “suspicious for malignancy” determined by needle core biopsy. Ann Surg Oncol. 2007;14:704–711
  22. O'Hea BJ, Tornos C. Mild ductal atypia after large-core needle biopsy of the breast: Is surgical excision always necessary?. Surgery. 2000;128:738–743
  23. Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol. 2001;25:1017–1021
  24. Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009;131:112–121
  25. Jackman RJ, Burbank F, Parker SH, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485–488
  26. Jackman RJ, Burbank F, Parker SH. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology. 2001;218:497–502
  27. Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology. 2002;224:548–554
  28. Jang M, Cho N, Moon WK, Park JS, Seong MH, Park IA. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2008;191:1347–1351
  29. Foote FW, Stewart FW. Lobular carcinoma in situ. Am J Pathol. 1941;491–495
  30. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42:737–769
  31. Page DL, Dupont WD, Rogers LW. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol. 1988;19:201–207
  32. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698–2708
  33. McLaren BK, Schuyler PA, Sanders ME, et al. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer. 2006;107:1227–1233
  34. Tavassoli FA, Millis RR, Boecker W, Lakhani SR. Lobular neoplasia. In:  Tavassoli FA,  Devilee P editor. World Health Organization Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003;p. 60–62
  35. Bratthauer GL, Moinfar F, Stamatakos MD, et al. Combined e-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol. 2002;33:620–627
  36. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232–1239
  37. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14:1008–1011
  38. Urban J. Bilaterality of cancer of the breast: Biopsy of the opposite breast. Cancer. 1967;20:1867–1870
  39. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2:225–251
  40. Hanby AM, Hughes TA. In situ and invasive lobular neoplasia of the breast. Histopathology. 2008;52:58–66
  41. Lakhani SR, Audretsch W, Cleton-Jensen AM, et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer. 2006;42:2205–2211
  42. Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol. 2008;32:1721–1726
  43. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000;24:1650–1656
  44. Andersen JA. Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand A. 1974;82:519–533
  45. Andersen JA. Lobular carcinoma in situ. A histologic study of 52 cases. Acta Pathol Microbiol Scand A. 1974;82:735–741
  46. Page DL, Schuyler PA, Dupont WD, et al. A typical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125–129
  47. Reis-Filho JS, Pinder SE. Non-operative breast pathology: lobular neoplasia. J Clin Pathol. 2007;60:1321–1327
  48. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29:534–543
  49. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 2006;187:949–954
  50. Tremblay G, Buell RH, Seemayer TA. Elastosis in benign sclerosing ductal proliferation of the female breast. Am J Surg Pathol. 1977;1:155–159
  51. Fisher ER, Palekar AS, Kotwal N, Lipana N. A non-encapsulated sclerosing lesion of the breast. Am J Clin Pathol. 1979;71:240–246
  52. Rickert RR, Kalisher L, Hutton RVP. Indurative mastopathy. A benign sclerosing lesion of the breast with elastosis which may simulate carcinoma. Cancer. 1981;47:561–571
  53. Nielsen M, Christensen L, Andersen J. Radial scars in women with breast cancer. Cancer. 1987;59:1019–1025
  54. Nielsen M, Jensen J, Andersen JA. An autopsy study of radial scar in the female breast. Histopathology. 1985;9:287–295
  55. Bhathal PS, Brown RW, Lesueur GC. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer. 1985;51:271–278
  56. Patterson JA, Scott M, Anderson N, Kirk SJ. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol. 2004;30:1065–1068
  57. Douglas-Jones AG, Pace DP. Pathology of R4 spiculated lesions in the breast screening programme. Histopathology. 1997;30:214–220
  58. Brodie C, O'Doherty A, Quinn C. Fourteen-gauge needle core biopsy of mammographically evident radial scars. Is excision necessary?. Cancer. 2003;97:652–653Correspondence: In reply to Cancer 2003; 97: 345–51
  59. Cawson JN, Malara F, Kavanagh A, Hill P, Balasubramanium G, Henderson M. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?. Cancer. 2003;97:345–351
  60. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology. 1993;23:225–231
  61. Doyle EM, Banville N, Quinn CM, et al. Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology. 2007;50:607–614
  62. Linell F, Ljungberg O, Andersson I. Breast carcinoma: aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand. 1980;272(Suppl):14–62
  63. De la Torre M, Wells AF, Bergh J, Lindgren A. Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol. 1993;24:1294–1297
  64. Jacobs TW, Byrne C, Colditz G, et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 1999;340:430–436
  65. Sanders ME, Simpson JF, Schuyler PA, Plummer WD, Dupont WD. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer. 2006;106:1453–1461
  66. Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008;108:167–174
  67. Fiks A. Cystosarcoma phyllodes of the mammary gland. Müller's tumour. For the 180th birthday of Johannes Müller. Virchows Arch A Pathol Anat Histol. 1981;392:1–6
  68. Ariel L. Skeletal metastases in cystosarcoma phyllodes. Arch Surg. 1961;82:275–280
  69. Maier WP, Rosemond GP, Wittenbert P, et al. Cystosarcoma phyllodes mammae. Oncology. 1968;22:145–158
  70. Noguchi S, Motomura K, Inaji H, et al. Clonal analysis of fibroadenoma and phyllodes tumor of the breast by means of polymerase chain reaction. Cancer Res. 1993;53:4071–4074
  71. Noguchi S, Yokouchi H, Aihara T, et al. Progression of fibroadenoma to phyllodes tumour demonstrated by clonal analysis. Cancer. 1995;76:1779–1785
  72. Karim RZ, Scolyer RA, Tse GM, Tan P, Putti TC, Lee CS. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology. 2009;41:105–117
  73. Oberman HA. Cystosarcoma phyllodes. A clinicopathologic study of hypercellular periductal stromal neoplasms of the breast. Cancer. 1965;18:697–710
  74. Draghi F, Sabolla L, Campani R, et al. Diagnostic imaging of phyllodes tumours: preliminary observations. Radiol Med (Torino). 1996;91:215–221
  75. Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993;71:3020–3024
  76. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer. 1978;41:1974–1983
  77. Katsohis CD, Fahandides E, Agurigakis C, Aletras HA. Cystosarcoma phyllodes of the breast. Int Surg. 1990;75:162–165
  78. Pantoja E, Llobet RE, Lopez E. Gigantic cystosarcoma phyllodes in a man with gynaecomastia. Arch Surg. 1976;111:611
  79. Young JF, Jensen PE, Wiley CA. Malignant phyllodes tumour of the prostate. A case report with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med. 1992;116:296–299
  80. Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer. 1996;77:910–916
  81. Moffat CJ, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of 32 cases. Histopathology. 1995;27:205–218
  82. Rosai J. Breast stromal tumors and tumorlike conditions. In:  Rosai J editors. Rosai and Ackerman's surgical pathology. vol. II:Philadelphia: Mosby; 2004;p. 1829–1830
  83. Azzopardi JG. Sarcoma in the breast. In:  Bennington J editors. Problems in breast pathology. vol. II:Philadelphia: WB Saunders; 1979;p. 355–359
  84. Salvadori B, Cusumano F, Del-Ro R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer. 1989;63:2532–2536
  85. Tavassoli FA. Biphasic tumours. In: Pathology of the breast. 2nd edn. Stamford, Connecticut: Appleton & Lange; 1999;p. 608
  86. Lee AHS, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology. 2007;51:336–344
  87. Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg. 2003;138:987–990
  88. Dillon MF, Quinn CM, McDermott EW, O'Doherty A, O'Higgins N, Hill AD. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery. 2006;140:779–784
  89. Murad TM, Contesso G, Mouriesse H. Papillary tumours of large lactiferous ducts. Cancer. 1981;48:122–133
  90. Woods ER, Helvie MA, Ikeda DM, Mandell SH, Chapel KL, Adler DD. Solitary breast papilloma: comparison of mammographic, galactographic and pathologic findings. AJR Am J Roentgenol. 1992;159:487–491
  91. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93:1046–1052
  92. Kim TH, Kang DK, Kim SY, Lee EJ, Jung YS, Yim H. Sonographic differentiation of benign and malignant papillary lesions of the breast. J Ultrasound Med. 2008;27:75–82
  93. Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78:258–266
  94. Tavassoli FA. Papillary lesions. In: Pathology of the breast. 2nd edn. Stamford, Connecticut: Appleton and Lange; 1999;p. 325–372
  95. Ellis CE, Elston CW, Pinder SE. Papillary lesions. In:  Elston CE,  Ellis IO editor. The breast. Edinburgh: Churchill Livingstone; 1998;p. 133–146
  96. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52:20–29
  97. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30:1002–1007
  98. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol. 2007;15:143–147
  99. Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 1995;19:1237–1244
  100. Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol. 2006;30:501–507
  101. Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple and atypical papilloma. Am J Surg Pathol. 2006;30:665–672
  102. Grabowski J, Salzstein SL, Sadler GR, Blair S. Intracystic papillary carcinoma: a review of 917 cases. Cancer. 2008;113:916–920
  103. Carder PJ, Garvican J, Haigh I, Liston JC. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology. 2005;46:320–327
  104. Ashkenazi I, Ferrer K, Sekosan M, et al. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg. 2007;194:183–188
  105. Feeley L, Quinn CM. Columnar cell lesions of the breast. Histopathology. 2008;52:11–19
  106. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521–1527
  107. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003;10:113–124
  108. Pandey S, Kornstein MJ, Shank W, Shaw de Paredes E. Columnar cell lesions of the breast: mammographic findings with histopathologic correlation. Radiographics. 2007;27:S79–S89
  109. Goldstein NS, Kestin LJ, Vicini FA. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am J Clin Pathol. 2007;128:1023–1034
  110. O'Malley FP, Mohsin SK, Badve S, et al. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006;19:172–179
  111. Pinder SE, Reis-Filho JS. Non-operative breast pathology: columnar cell lesions. J Clin Pathol. 2007;60:1307–1312
  112. Noel JC, Fayt I, Fernandez-Aguilar S, Buxant F, Boutemy R. Proliferating activity in columnar cell lesions of the breast. Virchows Arch. 2006;449:617–621
  113. Simpson PT, Gale T, Reis-Filho JS, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005;29:734–746
  114. Abdel-Fatah TMA, Powe DG, Hodi Z, Lee AHS, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31:417–426
  115. Tremblay G, Deschenes J, Alpert L, Quenneville LA. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J. 2005;11:326–332
  116. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999;23:1561
  117. Liebl S, Regitnig P, Moinfar F. Flat epithelial atypia (DIN 1A, atypical columnar cell change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology. 2007;50:859–865
  118. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European organisation for research and treatment of cancer trial 10853. J Clin Oncol. 2001;19:2263–2271
  119. Turashvili G, Hayes M, Gilks B, Watson P, Aparicio S. Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?. Virchows Arch. 2008;452:589–598
  120. De Mascarel I, MacGrogan G, Mathoulin-Pelissier S, et al. Epithelial atypia in biopsies performed for microcalcifications practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch. 2007;451:1–10
  121. Boulos FI, Dupont WD, Simpson JF, et al. Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and nested case-control study. Cancer. 2008;113:2415–2421
  122. Guerra-Wallace MM, Christensen WN, White RL. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg. 2004;188:395–398
  123. Tse GMK, Tan PH, Lui PCW, Putti TC. Spindle cell lesions of the breast – the pathologic differential diagnosis. Breast Cancer Res Treat. 2008;109:199–207
  124. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. Cancer. 1948;1:64–81
  125. Glazebrook KN, Magut MJ, Reynolds C. Angiosarcoma of the breast. AJR Am J Roentgenol. 2008;190:533–538

PII: S1756-2317(09)00142-X

doi: 10.1016/j.mpdhp.2009.07.004

Diagnostic Histopathology
Volume 15, Issue 10 , Pages 459-469 , October 2009

Article Tools

* Image Usage & Resolution